Nucleate NY x Princeton: Approach to Due Diligence

​Ever wonder how investors think about evaluating early-stage biotechnologies? Join us for Approach to Due Diligence, a seminar led by experts from the Princeton Office of Innovation. Learn about what goes into performing due diligence on an academic technology and the factors that predict its success.

​Speakers:

​Cortney Cavanaugh | As New Ventures and Licensing Associate, Cortney is responsible for assisting Princeton faculty and researchers in moving their work out of the lab and into the marketplace and wider society. This goal is accomplished through the management of intellectual property, preparation of commercialization strategies, and support of startups built around technologies from the University.

​Walida Ali | Walida Ali is the Innovation Development Manager at Princeton University for the NSF I-Corps Northeast Hub. She is a molecular bioengineer and businesswomen with expertise in deep tech venture creation, life sciences, and healthcare and is a National Science Foundation I-Corp alumni. In recent years, Walida oversaw portfolio strategy and supported scientific collaborations for a series B fundraising for a biotech company, and operations for NYC’s leading tech accelerator. Walida has supported over 40 leading Universities across the US through her work supporting at Academic Venture Exchange to translate scientific innovation and drive lab-to-market efforts. Alongside her work at Princeton University, Walida also independently supports early-stage biotech and medical device companies in health economics and market access.

​Agenda

​​12:00 PM - Intro to Nucleate Activator and Speakers

​12:10 PM - Intro to I-Corps Princeton

​12:20 PM - I-Corps Presents: How Investors Evaluate Academic Spinouts

​​12:50 PM - Q&A session

Zoom Link: https://us06web.zoom.us/j/87205322964